ABSTRACT SUBMISSION
CLOSING IN 2 WEEKS!
It has never been easier to submit your research on hepatology and liver disease than right now because #CLM2021 is going Virtual. We will have the most innovative and interactive poster program yet featuring on-demand talks and the ability for the audience to interact and ask questions to poster presenters. 

You have only 2 more weeks to submit your abstract for a poster or oral presentation! 
2021 Abstract Topics:

Viral Hepatitis –
  • Clinical Science
  • Biomedical/Basic Science
  • Epidemiology/Public Health

NAFLD/NASH –
  • Clinical Science
  • Biomedical/Basic Science
  • Epidemiology/Public Health

Other Liver Disease/General Hepatology –
  • Clinical Science
  • Biomedical/Basic Science
  • Epidemiology/Public Health
PRELIMINARY SCHEDULE NOW AVAILABLE
The CLM 2021 Program continues to develop and expand. Each day is filled with unique and engaging virtual sessions that are sure to deliver thought-provoking educational discussions.

Sessions include:
  • Progress toward WHO Interim Targets for Hepatitis: Elimination: National Elimination Check-ups
  • How Disparities Affect the Viral Hepatitis Elimination Agenda
  • Lived Experience Panel
  • How COVID has Impacted Viral Hepatitis and the Elimination Agenda
  • HCC After Cure of HCV or Suppression of HBV
  • Progress Toward an HCV Vaccine
  • HDV Cure
  • Quality Metrics for Cirrhosis Care

Be sure to visit the meeting website as speakers and sessions continue to be updated.
YOUR CLM 2021 HOSTS
CASL is a multidisciplinary group of scientists and healthcare providers whose expertise focuses on the liver, and provides national leadership in all aspects of research, education and patient care as they pertain to the liver. 

CASL is a non-profit organization that seeks to eliminate liver disease through research, education and advocacy. Its members include hepatologists, gastroenterologists, pathologists, pediatricians, radiologists, scientists, surgeons, trainees and other interested people.
 
CanHepC is a collaborative research network funded by the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC) dedicated to translational research linking over 100 researchers, trainees, knowledge-users (community members, community-based organizations, policy and decision makers) in the field of Hepatitis C (HCV) from across Canada as well as international partners.




Hepatology nursing is a specialized area of client-centered nursing that focuses on the promotion of liver health, prevention of illness, and the care of clients. Since most liver diseases are chronic in nature, hepatology nursing practice promotes self-care, advocates for resources, and supports the client through the illness experience.

AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. We foster research that leads to improved treatment options for millions of liver disease patients. We advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies.
For more information, contact us!